|
1
|
Lai EC, Tomancak P, Williams RW and Rubin
GM: Computational identification of Drosophila microRNA genes.
Genome Biol. 4:R422003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Danielson LS, Reavie L, Coussens M,
Davalos V, Castillo-Martin M, Guijarro MV, Coffre M, Cordon-Cardo
C, Aifantis I, Ibrahim S, et al: Limited miR-17-92 overexpression
drives hematologic malignancies. Leuk Res. 39:335–341. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Visone R and Croce CM: miRNAs and cancer.
Am J Pathol. 174:1131–1138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mendes ND, Freitas AT and Sagot MF:
Current tools for the identification of miRNA genes and their
targets. Nucleic Acids Res. 37:2419–2433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a-27a-24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar
|
|
8
|
He L, Thomson JM, Hemann MT,
Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe
SW, Hannon GJ, et al: A microRNA polycistron as a potential human
oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun J, Gao B, Zhou M, Wang ZZ, Zhang F,
Deng JE and Li X: Comparative genomic analysis reveals evolutionary
characteristics and patterns of microRNA clusters in vertebrates.
Gene. 512:383–391. 2013. View Article : Google Scholar
|
|
10
|
Ota A, Tagawa H, Karnan S, Tsuzuki S,
Karpas A, Kira S, Yoshida Y and Seto M: Identification and
characterization of a novel gene, C13orf25, as a target for
13q31-q32 amplification in malignant lymphoma. Cancer Res.
64:3087–3095. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ventura A, Young AG, Winslow MM, Lintault
L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone
JR, et al: Targeted deletion reveals essential and overlapping
functions of the miR-17 through 92 family of miRNA clusters. Cell.
132:875–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong MH, Mitchell DA, McGowan SD, Evanoff
R and Griswold MD: Two miRNA clusters, Mir-17-92 (Mirc1) and
Mir-106b-25 (Mirc3), are involved in the regulation of
spermato-gonial differentiation in mice. Biol Reprod. 86:722012.
View Article : Google Scholar
|
|
14
|
Mogilyansky E and Rigoutsos I: The
miR-17/92 cluster: A comprehensive update on its genomics,
genetics, functions and increasingly important and numerous roles
in health and disease. Cell Death Differ. 20:1603–1614. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hossain A, Kuo MT and Saunders GF:
Mir-17-5p regulates breast cancer cell proliferation by inhibiting
translation of AIB1 mRNA. Mol Cell Biol. 26:8191–8201. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong AY, Eischeid AN, Xiao J, Zhao J, Chen
D, Wang ZY, Young CY and Chen XM: miR-17 5p targets the
300/CBP-associated factor and modulates androgen receptor
transcriptional activity in cultured prostate cancer cells. BMC
Cancer. 12:4922012. View Article : Google Scholar
|
|
17
|
Yang X, Du WW, Li H, Liu F, Khorshidi A,
Rutnam ZJ and Yang BB: Both mature miR-17-5p and passenger strand
miR-17-3p target TIMP3 and induce prostate tumor growth and
invasion. Nucleic Acids Res. 41:9688–9704. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Vecchiarelli-Federico LM, Li YJ,
Egan SE, Spaner D, Hough MR and Ben-David Y: The miR-17-92 cluster
expands multipotent hematopoietic progenitors whereas imbalanced
expression of its individual oncogenic miRNAs promotes leukemia in
mice. Blood. 119:4486–4498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shrivastava S, Petrone J, Steele R, Lauer
GM, Di Bisceglie AM and Ray RB: Upregulation of circulating miR-20a
is correlated with hepatitis C virus-mediated liver disease
progression. Hepatology. 58:863–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Jiang J, Wang S and Xia X:
Oncogenic role of microRNA 20a in human uveal melanoma. Mol Med
Rep. 14:1560–1566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuo W, Ge W, Meng G, Jia S, Zhou X and
Liu J: MicroRNA 20a promotes the proliferation and cell cycle of
human osteosarcoma cells by suppressing early growth response 2
expression. Mol Med Rep. 12:4989–4994. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma
LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and
miR-106a enhance the invasiveness of human glioma stem cells by
directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar
|
|
23
|
Xiong Y, Zhang L and Kebebew E: miR-20a is
upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS
One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landais S, Landry S, Legault P and Rassart
E: Oncogenic potential of the miR-106-363 cluster and its
implication in human T-cell leukemia. Cancer Res. 67:5699–5707.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Zhang Z, Yu M, Li L, Du G, Xiao W
and Yang H: Involvement of miR-20a in promoting gastric cancer
progression by targeting early growth response 2 (EGR2). Int J Mol
Sci. 14:16226–16239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiang XF, Zhang ZW, Liu Q, Sun N, Pan LL,
Shen J, Li T, Yun C, Li H and Shi LH: miR-20a promotes prostate
cancer invasion and migration through targeting ABL2. J Cell
Biochem. 115:1269–1276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Olive V, Bennett MJ, Walker JC, Ma C,
Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ and He L: miR-19
is a key oncogenic component of mir-17-92. Genes Dev. 23:2839–2849.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsu TI, Hsu CH, Lee KH, Lin JT, Chen CS,
Chang KC, Su CY, Hsiao M and Lu PJ: MicroRNA-18a is elevated in
prostate cancer and promotes tumorigenesis through suppressing STK4
in vitro and in vivo. Oncogenesis. 3:e992014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niu H, Wang K, Zhang A, Yang S, Song Z,
Wang W, Qian C, Li X, Zhu Y and Wang Y: miR-92a is a critical
regulator of the apoptosis pathway in glioblastoma with inverse
expression of BCL2L11. Oncol Rep. 28:1771–1777. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsuchida A, Ohno S, Wu W, Borjigin N,
Fujita K, Aoki T, Ueda S, Takanashi M and Kuroda M: miR-92 is a key
oncogenic component of the miR-17-92 cluster in colon cancer.
Cancer Sci. 102:2264–2271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H
and Hu C: Circulating microRNA-92a and microRNA-21 as novel
minimally invasive biomarkers for primary breast cancer. J Cancer
Res Clin Oncol. 139:223–229. 2013. View Article : Google Scholar :
|
|
32
|
Santoro MM and Nicoli S: miRNAs in
endothelial cell signaling: The endomiRNAs. Exp Cell Res.
319:1324–1330. 2013. View Article : Google Scholar :
|
|
33
|
Doebele C, Bonauer A, Fischer A, Scholz A,
Reiss Y, Urbich C, Hofmann WK, Zeiher AM and Dimmeler S: Members of
the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic
function in endothelial cells. Blood. 115:4944–4950. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Venturini L, Battmer K, Castoldi M,
Schultheis B, Hochhaus A, Muckenthaler MU, Ganser A, Eder M and
Scherr M: Expression of the miR-17-92 polycistron in chronic
myeloid leukemia (CML) CD34+ cells. Blood.
109:4399–4405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shan SW, Lee DY, Deng Z, Shatseva T,
Jeyapalan Z, Du WW, Zhang Y, Xuan JW, Yee SP, Siragam V, et al:
MicroRNA miR-17 retards tissue growth and represses fibronectin
expression. Nat Cell Biol. 11:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Y, Choi PS, Casey SC, Dill DL and
Felsher DW: MYC through miR-17-92 suppresses specific target genes
to maintain survival, autonomous proliferation, and a neoplastic
state. Cancer Cell. 26:262–272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mestdagh P, Boström AK, Impens F, Fredlund
E, Van Peer G, De Antonellis P, von Stedingk K, Ghesquière B,
Schulte S, Dews M, et al: The miR-17-92 microRNA cluster regulates
multiple components of the TGF-β pathway in neuroblastoma. Mol
Cell. 40:762–773. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sokolova V, Fiorino A, Zoni E, Crippa E,
Reid JF, Gariboldi M and Pierotti MA: The effects of miR-20a on
p21: Two mechanisms blocking growth arrest in TGFbeta responsive
colon carcinoma. J Cell Physiol. 230:3105–3114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Woods K, Thomson JM and Hammond SM: Direct
regulation of an oncogenic micro-RNA cluster by E2F transcription
factors. J Biol Chem. 282:2130–2134. 2007. View Article : Google Scholar
|
|
40
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sylvestre Y, De Guire V, Querido E,
Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G and Chartrand P:
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem.
282:2135–2143. 2007. View Article : Google Scholar
|
|
42
|
Pichiorri F, Suh SS, Ladetto M, Kuehl M,
Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, et
al: MicroRNAs regulate critical genes associated with multiple
myeloma pathogenesis. Proc Natl Acad Sci USA. 105:12885–12890.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou P, Ma L, Zhou J, Jiang M, Rao E, Zhao
Y and Guo F: miR-17-92 plays an oncogenic role and conveys
chemo-resistance to cisplatin in human prostate cancer cells. Int J
Oncol. 48:1737–1748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dou L, Meng X, Sui X, Wang S, Shen T,
Huang X, Guo J, Fang W, Man Y, Xi J, et al: miR-19a regulates PTEN
expression to mediate glycogen synthesis in hepatocytes. Sci Rep.
5:116022015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi RU, Miyazaki H and Ochiya T: The
role of microRNAs in the regulation of cancer stem cells. Front
Genet. 4:2952014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hwang WL, Jiang JK, Yang SH, Huang TS, Lan
HY, Teng HW, Yang CY, Tsai YP, Lin CH, Wang HW, et al:
MicroRNA-146a directs the symmetric division of Snail-dominant
colorectal cancer stem cells. Nat Cell Biol. 16:268–280. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zagorac S, Alcala S, Fernandez Bayon G,
Bou Kheir T, Schoenhals M, González-Neira A, Fernandez Fraga M,
Aicher A, Heeschen C and Sainz B Jr: DNMT1 Inhibition reprograms
pancreatic cancer stem cells via upregulation of the miR-17-92
cluster. Cancer Res. 76:4546–4558. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cioffi M, Trabulo SM, Sanchez-Ripoll Y,
Miranda-Lorenzo I, Lonardo E, Dorado J, Reis Vieira C, Ramirez JC,
Hidalgo M, Aicher A, et al: The miR-17-92 cluster counteracts
quiescence and chemoresistance in a distinct subpopulation of
pancreatic cancer stem cells. Gut. 64:1936–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
He H and Magi-Galluzzi C:
Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat
Pathol. 21:174–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEBl and member of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:521–522. 2008. View Article : Google Scholar
|
|
52
|
Li J, Yang S, Yan W, Yang J, Qin YJ, Lin
XL, Xie RY, Wang SC, Jin W, Gao F, et al: MicroRNA-19 triggers
epithelial-mesenchymal transition of lung cancer cells accompanied
by growth inhibition. Lab Invest. 95:1056–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xi XP, Zhuang J, Teng MJ, Xia LJ, Yang MY,
Liu QG and Chen JB: MicroRNA-17 induces epithelial-mesenchymal
transition consistent with the cancer stem cell phenotype by
regulating CYP7B1 expression in colon cancer. Int J Mol Med.
38:499–506. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ottman R, Levy J, Grizzle WE and
Chakrabarti R: The other face of miR-17-92a cluster, exhibiting
tumor suppressor effects in prostate cancer. Oncotarget.
7:73739–73753. 2016.PubMed/NCBI
|
|
55
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: miR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar :
|
|
57
|
Landskroner-Eiger S, Qiu C, Perrotta P,
Siragusa M, Lee MY, Ulrich V, Luciano AK, Zhuang ZW, Corti F,
Simons M, et al: Endothelial miR-17-92 cluster negatively regulates
arteriogenesis via miRNA-19 repression of WNT signaling. Proc Natl
Acad Sci USA. 112:12812–12817. 2015. View Article : Google Scholar
|
|
58
|
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita
Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T,
Takahashi T, et al: miR-92a inhibits peritoneal dissemination of
ovarian cancer cells by inhibiting integrin α5 expression. Am J
Pathol. 182:1876–1889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhao S, Yao D, Chen J, Ding N and Ren F:
miR-20a promotes cervical cancer proliferation and metastasis in
vitro and in vivo. PLoS One. 10:e01209052015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang M, Liu Q, Mi S, Liang X, Zhang Z, Su
X, Liu J, Chen Y, Wang M, Zhang Y, et al: Both miR-17-5p and
miR-20a alleviate suppressive potential of myeloid-derived
suppressor cells by modulating STAT3 expression. J Immunol.
186:4716–4724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Dereani S, Macor P, D'Agaro T, Mezzaroba
N, Dal-Bo M, Capolla S, Zucchetto A, Tissino E, Del Poeta G, Zorzet
S, et al: Potential therapeutic role of antagomiR17 for the
treatment of chronic lymphocytic leukemia. J Hematol Oncol.
7:792014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Murphy BL, Obad S, Bihannic L, Ayrault O,
Zindy F, Kauppinen S and Roussel MF: Silencing of the miR-17-92
cluster family inhibits medulloblastoma progression. Cancer Res.
73:7068–7078. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chen J, Huang ZP, Seok HY, Ding J, Kataoka
M, Zhang Z, Hu X, Wang G, Lin Z, Wang S, et al: mir-17-92 cluster
is required for and sufficient to induce cardiomyocyte
proliferation in postnatal and adult hearts. Circ Res.
112:1557–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhou T, Zhang G, Liu Z, Xia S and Tian H:
Overexpression of miR-92a correlates with tumor metastasis and poor
prognosis in patients with colorectal cancer. Int J Colorectal Dis.
28:19–24. 2013. View Article : Google Scholar
|
